In December, PersonGen has successfully built a Nano-Antibody Screening Platform.

In October, PersonGen was approved to establish Suzhou Engineering Technology Research Center for Tumor Immunodiagnosis and Treatment.

In August, PersonGen obtained Angel Round Investment from Zhongxin Venture Capital.

In July, PersonGen was awarded the title of Private Technology Enterprise in Jiangsu Province.

In July, Dr. Lin YANG was awarded the Gusu Leading Talent of Innovation and Entrepreneurship.

In March, PersonGen built the 2nd and 3rd generation CAR-T Technology Platform.